Serial #99622570
LIVE

Serial Number

99622570

Owner

Avidity Biosciences, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Jan 29, 2026

Add to watchlist:

No watchlists yet
View on USPTO

Serial #99622570 Trademark

Serial Number: 99622570

Serial #99622570 is a trademark filed by Avidity Biosciences, Inc. on January 29, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Avidity Biosciences, Inc. (41 trademarks)

10578 Science Drive, Suite 125
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

January 29, 2026

Registration Date

Not Registered

Published for Opposition

June 30, 2026

Goods & Services

Custom manufacturing of oligonucleotide-conjugate based pharmaceutical therapies, oligonucleotide-antibody conjugate based pharmaceutical therapies, and oligonucleotide-antibody fragment conjugate based pharmaceutical therapies; custom manufacturing of pharmaceuticals; contract manufacturing in the field of pharmaceuticals; providing technical information in the field of pharmaceutical manufacturing

Medical and scientific research, namely, conducting clinical trials for others; providing medical and scientific research information in the fields of pharmaceuticals, biotechnology, and clinical trials; pharmaceutical research and development; pharmaceutical products development; research and development in the field of biotechnology; providing medical and scientific research information in the fields of pharmaceuticals, therapeutics, medicines and vaccines

Therapeutic pharmaceuticals in the nature of oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of and prevention of musculoskeletal, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, and muscle atrophy related diseases and disorders; pharmaceutical preparations for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, autoimmune, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, dermatological, psychiatric, genetic, and immune system related diseases and disorders; pharmaceutical preparations for the treatment and prevention of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; therapeutic pharmaceutical for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, autoimmune, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, neurodegenerative, gastrointestinal, hormonal, dermatological, psychiatric, genetic, and immune system related diseases and disorders; therapeutic pharmaceuticals for the treatment and prevention of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes

Providing information relating to the diagnostic, prophylactic and therapeutic properties in the field of pharmaceuticals, therapeutics, medicines, and vaccines; online medical information services, namely, providing a website related to the diagnostic, prophylactic and therapeutic properties of medicines and vaccines; none of the foregoing related to home health care services, skilled nursing services, medical and health care counseling and long-term health care planning performed by medical social workers, or medical care centers or clinics

Filing History

APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 2, 2026 CNSA
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 2, 2026 GNEN
EXAMINER'S AMENDMENT ENTERED
Jun 2, 2026 XAEC
EXAMINERS AMENDMENT E-MAILED
Jun 2, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 2, 2026 CNEA
ASSIGNED TO EXAMINER
May 27, 2026 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 22, 2026 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 22, 2026 NWOS
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 5, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 5, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 5, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 5, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 5, 2026 COAR
APPLICATION FILING RECEIPT MAILED
Jan 29, 2026 MAFR
NEW APPLICATION ENTERED
Jan 29, 2026 NWAP